Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-266,094
Closed -$14M 94
2025
Q2
$14M Sell
266,094
-80,662
-23% -$3.79M 4.49% 6
2025
Q1
$14.6M Sell
346,756
-268,056
-44% -$11.7M 4.65% 5
2024
Q4
$25.9M Buy
614,812
+193,590
+46% +$9.3M 6.45% 4
2024
Q3
$21M Buy
421,222
+132,554
+46% +$6.92M 6.3% 3
2024
Q2
$17.1M Buy
288,668
+54,797
+23% +$2.65M 5.02% 5
2024
Q1
$10.5M Sell
233,871
-267,935
-53% -$10.9M 2.78% 12
2023
Q4
$13.8M Buy
+501,806
New +$11.7M 3.68% 4

Other funds holding MRUS

Stempoint Capital's MRUS Position: Q3 2025 in Review

Stempoint Capital sold out of Merus (MRUS) in Q3 2025, closing a stake of 266,094 shares — an estimated $14M sold.

Stempoint Capital first reported a position in MRUS in Q4 2023 and held it in 7 quarters. The position peaked at $25.9M in Q4 2024. 268 funds tracked by Wall St. Rank hold MRUS as of Q3 2025.

  • Stempoint Capital reported no remaining Merus position as of Q3 2025 after selling out during the quarter.
  • Stempoint Capital sold 266,094 Merus shares in Q3 2025, an estimated $14M.
  • Stempoint Capital first reported a position in Merus in Q4 2023 and held it in 7 quarters.
  • Stempoint Capital's Merus position peaked at $25.9M in Q4 2024.
  • 268 funds tracked by Wall St. Rank held Merus as of Q3 2025.

Based on Stempoint Capital's 13F filing for Q3 2025, filed 14 Nov 2025.